What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?

od Šíma, Martin, Michaličková, Danica, Slanař, Ondřej
izdano v Pharmaceutics (2021)

Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets

od Ľupták, Matej, Michaličková, Danica, Fišar, Zdeněk, Kitzlerová, Eva, Hroudová, Jana
izdano v World J Psychiatry (2021)

Profiling of microorganism-binding serum antibody specificities in professional athletes

od Minić, Rajna, Papić, Zlatko, Đorđević, Brižita, Michaličkova, Danica, Ilić, Vesna, Mathiesen, Geir, Živković, Irena, Pantic, Visnja, Dimitrijević, Ljiljana
izdano v PLoS One (2018)

Effects of Probiotic Supplementation on Selected Parameters of Blood Prooxidant‐Antioxidant Balance in Elite Athletes: A Double‐Blind Randomized Placebo‐Controlled Study

od Michalickova, Danica, Kotur-Stevuljevic, Jelena, Miljkovic, Milica, Dikic, Nenad, Kostic-Vucicevic, Marija, Andjelkovic, Marija, Koricanac, Vladimir, Djordjevic, Brizita
izdano v J Hum Kinet (2018)

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

od Michaličková, Danica, Jansa, Pavel, Bursová, Miroslava, Hložek, Tomáš, Čabala, Radomír, Hartinger, Jan Miroslav, Ambrož, David, Aschermann, Michael, Lindner, Jaroslav, Linhart, Aleš, Slanař, Ondřej, Krekels, Elke H.J.
izdano v Pulm Circ (2020)